TORNTPHARM.NS

Torrent Pharmaceuticals Limited · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$15.54B

PE Ratio

52.88

EV to Ebitda

—

Earnings Yield

2.00%

Revenue (TTM)

$1.33B

Net Income (TTM)

$293.9M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

18.00%

Profit Margin

18.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$15.54B

Revenue TTM$1.33B

Shares Outstanding338.4M

Float96942493

Insider Ownership71.00%

Institutional Ownership15.00%

Growth Estimates6 fields›

Revenue Growth (Quarterly YoY)18.00%

Rev Growth Est 1Y Forward0.37

EPS Growth (Quarterly YoY)26.00%

EPS Growth Est Quarterly18.66

LT EPS Growth Estimates-1.00%

EBITDA Growth (Quarterly YoY)12.00%

Operations19 fields›

Revenue TTM$1.33B

Gross Margin TTM76.00%

Gross Margin (Quarterly)75.00%

Operating Margin TTM27.00%

Operating Margin (Quarterly)27.00%

Operating Expenses TTM$21.4M

Profit Margin TTM18.00%

Profit Margin (Quarterly)20.00%

Net Income TTM$293.9M

EPS TTM67.3

EPS (Quarterly)18.76

EBITDA Margin TTM32.00%

EBITDA Margin (Quarterly)33.00%

EBITDA TTM$427.6M

CFO TTM$183.1M

Capex % of Revenue TTM6.00%

Capital Expenditures$84.2M

FCF % of Revenue (Quarterly)15.00%

FCF TTM$183.1M

Efficiency1 fields›

ROA13.00%

Valuation5 fields›

P/E (TTM)52.88

P/E Forward56.5

EV/Revenues (TTM)11.97

Earnings Yield2.00%

Payout Ratio66.00%

Liquidity5 fields›

Cash Per Share20.42

Current Ratio1.19

Total Assets$1.71B

Shareholders Equity$928.9M

Interest Expense$21.4M

Yields3 fields›

Payout Ratio66.00%

Earnings Yield2.00%

Buyback Yield0.00%